Clinical Trial

A Pilot Study Evaluating the Impact of a Prebiotic Soda on Gastrointestinal Symptoms in Users of GLP-1 Agonists

Completed
View on ClinicalTrials.gov →
Summary
The main objective of this study is to assess the impact of drinking a prebiotic soda on the gastrointestinal (GI) symptoms associated with the use of GLP-1 receptor agonists compared to usual fluid intake.
Trial Details
NCT Number NCT07744360
Lead Sponsor Olipop, PBC
Conditions GI Symptoms
Enrollment 80 participants
Start Date 2026-02-10
Primary Completion 2026-05-04 (estimated)
Study Completion 2026-06-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-04